TAI · 1734.TW
Sinphar Pharmaceutical Co. Ltd.
NT$30.55-NT$0.20 (-0.65%)
Sinphar Pharmaceutical Co. Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.86% below the high.
Loading market information…
TAI · 1786.TW · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
SciVision Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 48.15% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
SciVision Biotech Inc.’s forward annual dividend is NT$1.91 per share, paid annual. The forward yield is 4.01% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
SciVision Biotech Inc.’s next earnings report is currently expected on Oct 30, 2026, with estimated earnings per share of NT$1.04. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow SciVision Biotech Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:53 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| NT$204.34M-13.05% vs estimate |
| Q4 2024 | Mar 6, 2025 | NT$1.170.0% vs estimate | NT$255.20M+0.08% vs estimate |
|---|
| Q3 2024 | Nov 7, 2024 | NT$0.80-41.61% vs estimate | NT$222.00M-17.16% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$30.55-NT$0.20 (-0.65%)
Sinphar Pharmaceutical Co. Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.86% below the high.
NT$51.00-NT$0.60 (-1.16%)
SCI Pharmtech, Inc.’s quoted price sits in the upper half of its reported 52-week range, 15.98% below the high.
NT$45.40-NT$3.10 (-6.39%)
OBI Pharma, Inc.’s quoted price sits in the upper half of its reported 52-week range, 32.04% below the high.
NT$127.00NT$0.00 (0.0%)
Hi-Clearance Inc.’s quoted price sits in the lower half of its reported 52-week range, 7.97% below the high.
NT$75.50+NT$0.20 (+0.27%)
Pacific Hospital Supply Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 15.83% below the high.
NT$88.10-NT$0.40 (-0.45%)
Formosa Optical Technology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.05% below the high.
NT$53.20-NT$1.20 (-2.21%)
Ever Fortune.AI Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.26% below the high.
NT$90.20-NT$1.20 (-1.31%)
St.Shine Optical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.19% below the high.
